Emily Harris, MD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Image
Emily Harris, MD
Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Medical Services
Languages
English
Education
Undergraduate School
Duke University
2015
Durham
NC
Medical School
Columbia University Vagelos College of Physicians & Surgeons
2019
New York
NY
Internship
Pediatrics
Boston Combined Residency Program (BCRP)
2020
Boston
MA
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
2022
Boston
MA
Fellowship
Pediatric Hematology-Oncology
Boston Children's Hospital/Dana-Farber Cancer Institute
2025
Boston
MA
Certifications
American Board of Pediatrics (General)
Publications
T cell and autoantibody profiling for primary immune regulatory disorders. View Abstract
T follicular helper cells in primary immune regulatory disorders. View Abstract
Critical Bleeding in Adults and Children with Immune Thrombocytopenia: A Multicenter Cohort Study. View Abstract
Acute Promyelocytic Leukemia With Torque Teno Mini Virus::RARA Fusion: An Approach to Screening and Diagnosis. View Abstract
The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain. View Abstract
Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease. View Abstract
Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study. View Abstract
Utilization of an ITP quality improvement pathway improves adherence to management guidelines. View Abstract
Characteristics and outcomes of autoimmune hemolytic anemia after pediatric allogeneic stem cell transplant. View Abstract
Response to rituximab in children and adults with immune thrombocytopenia (ITP). View Abstract
Fever, Cough, and Flank Pain in a 10-year-old Boy. View Abstract
A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease. View Abstract
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. View Abstract
Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer. View Abstract
The role of ß-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome. View Abstract